Literature DB >> 31377833

Preoperative imaging for locoregional staging of bladder cancer.

S Mojdeh Mirmomen1, Atul B Shinagare2,3, Kristin E Williams2,3, Stuart G Silverman3, Ashkan A Malayeri4,5.   

Abstract

Bladder cancer is the ninth most common cancer, expected to lead to an estimated 17,670 deaths in the United States in 2019. Clinical management and prognosis of bladder cancer mainly depend on the extent of locoregional disease, particularly whether bladder muscle is involved. Therefore, bladder cancer is often divided into superficial, non-muscle-invasive bladder cancer and muscle-invasive bladder cancer; the latter often prompts consideration for cystectomy. While precise staging prior to cystectomy is crucial, the optimal preoperative imaging modality used to stage the disease remains controversial. Transurethral resection of bladder tumor (TURBT) followed by computed tomography (CT) urography is the current recommended approach for staging bladder cancer but suffers from a high rate of understaging. We review the recent literature and compare different imaging modalities for assessing the presence of muscle invasion and lymph node involvement prior to cystectomy and highlight the advantages of each modality.

Entities:  

Keywords:  Bladder cancer staging; Computed tomography; Magnetic resonance imaging; Positron emission tomography; Preoperative imaging modality

Year:  2019        PMID: 31377833     DOI: 10.1007/s00261-019-02168-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  9 in total

Review 1.  Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings.

Authors:  Rashmi Balasubramanya; Alampady K Shanbhogue; Nisha S Ramani; Ajaykumar C Morani; Ashish Khandelwal; Srinivasa R Prasad
Journal:  Abdom Radiol (NY)       Date:  2022-06-15

Review 2.  Neuroendocrine Neoplasms of the Female Genitourinary Tract: A Comprehensive Overview.

Authors:  Mayur Virarkar; Sai Swarupa Vulasala; Dheeraj Gopireddy; Ajaykumar C Morani; Taher Daoud; Rebecca Waters; Priya Bhosale
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 3.  The Role of Imaging in Bladder Cancer Diagnosis and Staging.

Authors:  Samuel J Galgano; Kristin K Porter; Constantine Burgan; Soroush Rais-Bahrami
Journal:  Diagnostics (Basel)       Date:  2020-09-16

Review 4.  Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.

Authors:  Maria Lucia Iacovino; Chiara Carmen Miceli; Marco De Felice; Biagio Barone; Luca Pompella; Francesco Chiancone; Erika Di Zazzo; Giuseppe Tirino; Carminia Maria Della Corte; Ciro Imbimbo; Ferdinando De Vita; Felice Crocetto
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

5.  Underlying mechanisms of change in cancer prevalence in older U.S. adults: contributions of incidence, survival, and ascertainment at early stages.

Authors:  I Akushevich; A Yashkin; M Kovtun; A I Yashin; J Kravchenko
Journal:  Cancer Causes Control       Date:  2022-07-07       Impact factor: 2.532

Review 6.  [Urothelial Carcinoma of the Bladder: Radiologic Perspective].

Authors:  Dong Won Kim; Seong Kuk Yoon; Sang Hyeon Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-09-15

Review 7.  The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.

Authors:  Vincenzo Cuccurullo; Giuseppe Danilo Di Stasio; Francesco Manti; Pierpaolo Arcuri; Rocco Damiano; Giuseppe Lucio Cascini
Journal:  Diagnostics (Basel)       Date:  2021-05-11

Review 8.  Imaging of Bladder Cancer: Standard Applications and Future Trends.

Authors:  Rasha Taha Abouelkheir; Abdalla Abdelhamid; Mohamed Abou El-Ghar; Tarek El-Diasty
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

9.  Deep Learning on Enhanced CT Images Can Predict the Muscular Invasiveness of Bladder Cancer.

Authors:  Gumuyang Zhang; Zhe Wu; Lili Xu; Xiaoxiao Zhang; Daming Zhang; Li Mao; Xiuli Li; Yu Xiao; Jun Guo; Zhigang Ji; Hao Sun; Zhengyu Jin
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.